Novadiscovery
Novadiscovery helps drug developers predict clinical trial outcomes and optimize study designs using virtual patients, reducing risk and cost before human testing. The company provides jinkō, an in silico clinical trial simulation platform that uses computational modeling, mathematical algorithms, and digital patient cohorts to run thousands of trial scenarios and generate synthetic control arms, identify best responders, and optimize regimens. Nova operates as a B2B SaaS platform serving pharmaceutical and biotech companies, academic research centers, and not-for-profit organizations. The platform centers on modeling & simulation technologies and integrates into R&D workflows to inform trial planning and decision-making. Novadiscovery addresses the drug development market by de-risking trials, shortening development timelines, and improving the probability of clinical success.
Novadiscovery
Novadiscovery helps drug developers predict clinical trial outcomes and optimize study designs using virtual patients, reducing risk and cost before human testing. The company provides jinkō, an in silico clinical trial simulation platform that uses computational modeling, mathematical algorithms, and digital patient cohorts to run thousands of trial scenarios and generate synthetic control arms, identify best responders, and optimize regimens. Nova operates as a B2B SaaS platform serving pharmaceutical and biotech companies, academic research centers, and not-for-profit organizations. The platform centers on modeling & simulation technologies and integrates into R&D workflows to inform trial planning and decision-making. Novadiscovery addresses the drug development market by de-risking trials, shortening development timelines, and improving the probability of clinical success.